Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Is self-rationing of medications a good or a bad thing?

Trudy Lieberman
Meds
June 6, 2013
Share
Tweet
Share

In America, the conventional wisdom is that we don’t ration health care. But we do, and there’s no better example than patients rationing themselves when it comes to the medicines they take.

Recently, a young twenty-something I know had a nagging cough—seasonal allergies, her doctor said and prescribed a generic medicine for asthma and allergies. She did not fill the prescription—the $160 price tag was too steep. Although she had health insurance from her employer, she had declined drug coverage because it was expensive and being young and healthy, she figured she could swing the bill for an occasional antibiotic.

At my local pharmacy, I have observed other patients walking away empty-handed after they learn the price of their medicines. When one woman was told the price for a skin ointment that was more than $600, she left the package on the counter and walked away. When the pharmacist tells customers they must now pay hundreds of dollars in coinsurance for a refill because their benefits have changed, they walk away too.

People are shocked to learn at the counter that their insurance company (or their employer who actually chooses the coverage) has switched from a plan with modest copayments—a set amount for prescriptions—to coinsurance, a percentage of the bill that is almost always more costly to the patient. All this is a form of health care self-rationing, and although it has always gone on to some extent, it is now showing up in Americans’ consumption of prescription drugs.

Last year, spending on prescription drugs fell for the first time in 58 years, according to IMS Institute for Health care Informatics. Not only has total spending on prescriptions dropped, but per capita spending has gone down too, from $931 to $898. Perhaps those declines suggest that the American love affair with prescription medicines – at least expensive ones – is fading.

Even though people are using more lower-cost generic drugs, that doesn’t mean generics always fit the pocketbook. The twenty-something who needed the seasonal allergy medication found that even the generic drug her doctor prescribed did not fit hers.

Affordability is a big problem that goes hand-in-hand with higher cost-sharing and out-of-pocket costs that even people with insurance are being asked to pay. As deductibles rise and the more expensive coinsurance is substituted for the cheaper copayments, there will be more self-rationing.

There may be clinical reasons for self-rationing as well. We know that patient compliance with prescription regimens is also a big problem, but when so many drugs now come with severe side effects, it’s understandable why some people self-ration and don’t take their meds. The treatment may be worse than the disease.

The of doctor prescribing patterns by ProPublica, the online investigative news organization, makes a case for clinical self-rationing. ProPublica found that doctors and other health care professionals were prescribing “large quantities of drugs that are potentially harmful, disorienting or addictive.”

Using Medicare data, ProPublica reporters discovered, for example, a Miami psychiatrist who gave hundreds of dementia patients an antipsychotic drug even though it carried the government’s most serious “black box” warning that the drug increases the risk of death. The reporters also found that in 2010, health care professionals wrote more than 500,000 prescriptions for the muscle relaxant carisoprodol, also known as Soma, even though it was pulled from the European market in 2007. The drug is also on the list of medications seniors should avoid, as published by the American Geriatrics Society. ProPublica found too that Medicare is not doing such a hot job of monitoring questionable medications.

So ProPublica has provided consumers with a tool for checking up on their doctors and asking some sharp questions about why they are asked to take certain drugs. That should be standard operating procedure for an engaged patient.

And that leads to the question: Is self-rationing of medications a good or a bad thing?  If your doctor prescribes some drug that Europeans have banned from the market, or one that carries a black box warning (which I have had doctors tell me to ignore), then self-rationing might be a good step along with finding a new doctor.

On the other hand, the twenty-something’s cough continued to worsen. Finally, she broke down and paid the asking price for the drug. Relief was on the way within a couple of hours. In medicine, very little is black or white — even rationing.

ADVERTISEMENT

Trudy Lieberman is a journalist and an adjunct associate professor of public health, Hunter College. She blogs regularly on the Prepared Patient Forum.

Prev

Cultivate more upstreamists to transform health care

June 6, 2013 Kevin 1
…
Next

To improve patient safety, lawyers need to embrace transparency too

June 6, 2013 Kevin 14
…

Tagged as: Medications

Post navigation

< Previous Post
Cultivate more upstreamists to transform health care
Next Post >
To improve patient safety, lawyers need to embrace transparency too

ADVERTISEMENT

More by Trudy Lieberman

  • Health care’s future: An interview with a hospital CEO

    Trudy Lieberman
  • How to choose a good hospital? Hint: Don’t listen to the ads.

    Trudy Lieberman
  • a desk with keyboard and ipad with the kevinmd logo

    Yes, we do ration health care in America

    Trudy Lieberman

More in Meds

  • My persistent adverse reaction to an SSRI

    Scott McLean
  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • The case for regulating, not banning, kratom

    Heidi Sykora, DNP, RN
  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • The unfair war on buprenorphine

    Brian Lynch, MD
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • Most Popular

  • Past Week

    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
    • The difference between a doctor and a physician

      Mick Connors, MD | Physician
    • How undermining physicians harms society

      Olumuyiwa Bamgbade, MD | Physician
    • Paraphimosis and diabetes: the hidden link

      Shirisha Kamidi, MD | Physician
    • What psychiatry can teach all doctors

      Farid Sabet-Sharghi, MD | Physician
  • Past 6 Months

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • The hypocrisy of insurance referral mandates

      Ryan Nadelson, MD | Physician
    • A cancer doctor’s warning about the future of medicine

      Banu Symington, MD | Physician
  • Recent Posts

    • Paraphimosis and diabetes: the hidden link

      Shirisha Kamidi, MD | Physician
    • Silicon Valley’s primary care doctor shortage

      George F. Smith, MD | Physician
    • Why women in medicine need to lift each other up [PODCAST]

      The Podcast by KevinMD | Podcast
    • The problem with laboratory reference ranges

      Larry Kaskel, MD | Conditions
    • My persistent adverse reaction to an SSRI

      Scott McLean | Meds
    • Why carrier screening results are complex

      Oluyemisi Famuyiwa, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 7 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • Rethinking cholesterol and atherosclerosis

      Larry Kaskel, MD | Conditions
    • The difference between a doctor and a physician

      Mick Connors, MD | Physician
    • How undermining physicians harms society

      Olumuyiwa Bamgbade, MD | Physician
    • Paraphimosis and diabetes: the hidden link

      Shirisha Kamidi, MD | Physician
    • What psychiatry can teach all doctors

      Farid Sabet-Sharghi, MD | Physician
  • Past 6 Months

    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The dismantling of public health infrastructure

      Ronald L. Lindsay, MD | Physician
    • Why doctors are losing the health care culture war

      Rusha Modi, MD, MPH | Policy
    • The hypocrisy of insurance referral mandates

      Ryan Nadelson, MD | Physician
    • A cancer doctor’s warning about the future of medicine

      Banu Symington, MD | Physician
  • Recent Posts

    • Paraphimosis and diabetes: the hidden link

      Shirisha Kamidi, MD | Physician
    • Silicon Valley’s primary care doctor shortage

      George F. Smith, MD | Physician
    • Why women in medicine need to lift each other up [PODCAST]

      The Podcast by KevinMD | Podcast
    • The problem with laboratory reference ranges

      Larry Kaskel, MD | Conditions
    • My persistent adverse reaction to an SSRI

      Scott McLean | Meds
    • Why carrier screening results are complex

      Oluyemisi Famuyiwa, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Is self-rationing of medications a good or a bad thing?
7 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...